Search research articles
Contact Us
Filters
Showing results (1-10 of 143) with videos related to
Page
of 15
Sort By:
European Urology
|
November 29, 2022
Uncertainty Persists Regarding the Role of Immunotherapy for Treatment of Metastatic Renal Cell Carcinoma with Favourable Prognosis
Chiara Ciccarese, Roberto Iacovelli
The New England Journal of Medicine
|
January 21, 2016
Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer
Chiara Ciccarese, Matteo Santoni, Francesco Massari
European Urology
|
January 4, 2016
Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR?
Chiara Ciccarese, Francesco Massari, Giampaolo Tortora
Current Opinion in Urology
|
April 10, 2024
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era
Giulio Francolini, Riccardo Campi, Chiara Ciccarese, et al.
The Lancet. Oncology
|
April 14, 2025
Belzutifan in von Hippel-Lindau disease
Chiara Ciccarese, Roberto Iacovelli, Giampaolo Tortora
Future Oncology (London, England)
|
March 24, 2016
2015 and human cancer: back to overall survival
Chiara Ciccarese, Francesco Massari, Giampaolo Tortora
Future Science OA
|
December 30, 2016
Acquired hemophagocytic syndrome: comment to the case report
Chiara Ciccarese, Francesco Massari, Giampaolo Tortora
Expert Opinion on Biological Therapy
|
June 12, 2015
The immunocheckpoints in modern oncology: the next 15 years
Francesco Massari, Matteo Santoni, Chiara Ciccarese, et al.
Clinical Genitourinary Cancer
|
August 25, 2018
De Novo, Progressed, and Neglected Metastatic Castration-Sensitive Prostate Cancer: Is One Therapy Fit for All?
Roberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
The Lancet. Oncology
|
February 7, 2019
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma
Roberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 143) with videos related to
Sort By:
Page
of 15
European Urology
|
November 29, 2022
Uncertainty Persists Regarding the Role of Immunotherapy for Treatment of Metastatic Renal Cell Carcinoma with Favourable Prognosis
Chiara Ciccarese, Roberto Iacovelli
The New England Journal of Medicine
|
January 21, 2016
Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer
Chiara Ciccarese, Matteo Santoni, Francesco Massari
European Urology
|
January 4, 2016
Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR?
Chiara Ciccarese, Francesco Massari, Giampaolo Tortora
Current Opinion in Urology
|
April 10, 2024
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era
Giulio Francolini, Riccardo Campi, Chiara Ciccarese, et al.
The Lancet. Oncology
|
April 14, 2025
Belzutifan in von Hippel-Lindau disease
Chiara Ciccarese, Roberto Iacovelli, Giampaolo Tortora
Future Oncology (London, England)
|
March 24, 2016
2015 and human cancer: back to overall survival
Chiara Ciccarese, Francesco Massari, Giampaolo Tortora
Future Science OA
|
December 30, 2016
Acquired hemophagocytic syndrome: comment to the case report
Chiara Ciccarese, Francesco Massari, Giampaolo Tortora
Expert Opinion on Biological Therapy
|
June 12, 2015
The immunocheckpoints in modern oncology: the next 15 years
Francesco Massari, Matteo Santoni, Chiara Ciccarese, et al.
Clinical Genitourinary Cancer
|
August 25, 2018
De Novo, Progressed, and Neglected Metastatic Castration-Sensitive Prostate Cancer: Is One Therapy Fit for All?
Roberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
The Lancet. Oncology
|
February 7, 2019
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma
Roberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
Page
of 15